Consistent with the results in the ICGC cohort, MAP2K2, NRAS, and EGF were found to be significantly up-expressed, whereas MCCs were significantly down-expressed in HCC (all P < 0.0001, Figures 4A–D). The gene discussed is MAP2K2; the disease is hepatocellular carcinoma.